N/A N=16 Diagnostic

Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer

Breast Cancer

Bottom Line

View on ClinicalTrials.gov: NCT03190083 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2020

Primary outcome: Primary: Number of Participants for Which DBT Altered Surgical Plan — 0 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: 2-dimensional mammogram (Device); digital breast tomosynthesis (DBT) (Device)
Age: Adult, Older Adult · 25+ yrs
Sex: Female
Sponsor: Case Comprehensive Cancer Center
Primary completion: Jun 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants for Which DBT Altered Surgical Plan	—	—

Summary

The purpose of this study is to determine if a 3-dimensional mammogram (DBT) may provide additional information to evaluate the extent of disease and additional findings that would aid in staging a new breast cancer patient. This would impact surgical planning and improve patient outcomes.

Eligibility Criteria

Inclusion Criteria

New diagnosis of breast cancer
New diagnosis if a previous breast cancer patient with negative surgical margins
Patients willing to sign a written informed consent form

Exclusion Criteria

High risk benign lesions as the primary pathology diagnosis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03190083). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.